CONMED Corporation (CNMD) Free Cash Flow
CONMED Corporation (CNMD) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $30.31M |
| 2017-12-31 | $52.72M |
| 2018-12-31 | $58.19M |
| 2019-12-31 | $75.07M |
| 2020-12-31 | $54.72M |
| 2021-12-31 | $96.90M |
| 2022-12-31 | $11.58M |
| 2023-12-31 | $106.32M |
| 2024-12-31 | $153.88M |
| 2025-12-31 | $150.88M |
How CNMD compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| PEN | Penumbra Inc. | $174.93M |
| EBS | Emergent BioSolutions Inc. | $156.80M |
| VCYT | Veracyte Inc. | $126.63M |
| AMPH | Amphastar Pharmaceuticals Inc. | $118.98M |
| ADUS | Addus HomeCare Corporation | $103.79M |
These are five companies in the same sector as CNMD with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get CONMED Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("CNMD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CNMD | $49.43 | +0.63% | 0.30M |
| 3 | ||||
| 4 | ||||
| 5 |